Insider Selling: IBEX (NASDAQ:IBEX) Director Sells $126,200.00 in Stock

Key Points

• IBEX Director Patrick McGinnis sold 2,500 shares for $126,200, reducing his direct stake by 35.29% to 4,585 shares.
• IBEX beat quarterly expectations, reporting earnings of $1.10 per share versus $0.90 expected and revenue of $175.23 million versus $169.31 million expected.
• The stock recently traded at $52.23, near its 52-week high, while analysts’ average rating was Hold with a $44.50 consensus price target.

IBEX Limited (NASDAQ:IBEX - Get Free Report) Director Patrick McGinnis sold 2,500 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $50.48, for a total value of $126,200.00. Following the sale, the director directly owned 4,585 shares in the company, valued at $231,450.80. This trade represents a 35.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

IBEX Price Performance

Shares of IBEX stock traded up $1.95 during mid-day trading on Tuesday, hitting $52.23. 432,801 shares of the stock traded hands, compared to its average volume of 124,838. IBEX Limited has a 52-week low of $25.94 and a 52-week high of $52.29. The stock has a market cap of $696.75 million, a P/E ratio of 15.83 and a beta of 0.74. The stock's fifty day moving average is $43.25 and its two-hundred day moving average is $34.57.

IBEX (NASDAQ:IBEX - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.20. The firm had revenue of $175.23 million during the quarter, compared to analysts' expectations of $169.31 million. IBEX had a return on equity of 28.96% and a net margin of 7.19%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on IBEX. Royal Bank Of Canada increased their price objective on IBEX from $40.00 to $45.00 and gave the company a "sector perform" rating in a report on Tuesday. Robert W. Baird lifted their target price on IBEX from $40.00 to $44.00 and gave the stock a "neutral" rating in a report on Monday, September 28th. Weiss Ratings upgraded IBEX from a "buy (b-)" rating to a "buy (b)" rating in a research report on Monday, October 12th. Finally, Wall Street Zen upgraded shares of IBEX from a "buy" rating to a "strong-buy" rating in a report on Saturday. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $44.50.

IBEX News Roundup

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of IBEX. Dimensional Fund Advisors LP boosted its stake in shares of IBEX by 7.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company's stock worth $9,607,000 after acquiring an additional 24,942 shares in the last quarter. Pinnacle Associates Ltd. increased its stake in shares of IBEX by 3.4% in the 3rd quarter. Pinnacle Associates Ltd. now owns 208,027 shares of the company's stock valued at $8,999,000 after purchasing an additional 6,932 shares in the last quarter. Tieton Capital Management LLC purchased a new position in shares of IBEX in the 2nd quarter valued at about $8,353,000. Hillsdale Investment Management Inc. boosted its position in IBEX by 2.8% during the first quarter. Hillsdale Investment Management Inc. now owns 264,200 shares of the company's stock worth $7,086,000 after purchasing an additional 7,300 shares in the last quarter. Finally, Globeflex Capital L P purchased a new position in IBEX during the second quarter worth approximately $3,112,000. Institutional investors and hedge funds own 81.24% of the company's stock.

IBEX Company Profile

IBEX Limited NASDAQ: IBEX is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.